Risk of Progression Independent of Relapse Activity and Disability Accumulation in a Real-world Cohort of Multiple Sclerosis Patients Initiated on High-efficacy Versus Low-efficacy Disease Modifying Therapy (P8-1.011)
To determine whether high-efficacy early therapy (HEET) compared to low-efficacy early therapy (LEET) affects risk of PIRA and sustained disability.
Authors
- Jessica Ye (ORCID: https://orcid.org/0000-0001-8392-7423)
- Brian C. Healy (ORCID: https://orcid.org/0000-0001-5272-2425)
- Tanuja Chitnis (ORCID: https://orcid.org/0000-0002-9897-4422)
- Negar Molazadeh (ORCID: https://orcid.org/0000-0003-0861-2178)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210349
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00